Skip to content

Clinical efficacy study of total gastrectomy for gastric cancer with the complete da Vinci robot

Clinical efficacy study of total gastrectomy for gastric cancer with the complete da Vinci robot

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074545
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-08-10
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Test group:Complete da Vinci robotic total gastrectomy

Sponsors

Second Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) all diagnosed gastric cancer by gastroscopy or pathological biopsy; (2) tumor site was proximal stomach, gastric fundus, gastric body or gastric sinus; (3) no distant metastasis and invasion of neighboring organs; (4) no other malignant tumors; and (5) complete da Vinci robotic total gastrectomy was taken.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) emergency surgery; (2) tumor site is distal stomach; (3) postoperative pathological diagnosis of benign tumor, residual gastric cancer, etc.; (4) accompanied by metastasis to adjacent organs or distant metastasis; (5) palliative surgery.

Design outcomes

Primary

MeasureTime frame
overall survival;Duration of surgery;Number of lymph nodes cleared;progression free survival;Intraoperative bleeding;Time of first postoperative meal;Drainage on the first postoperative day;Time to first postoperative activity;Drainage tube removal time;Post-operative hospitalization;Tumor markers;Histopathology;gastroscopy (medicine);Imaging examination;TNM staging;immunological markers;

Secondary

MeasureTime frame
hospital fees;Infectious indicators;Liver function;Nutrition indicators;Blood routine ;Coagulation function;

Countries

China

Contacts

Public ContactHao Chen

The Second Hospital of Lanzhou University

ery_chenh@lzu.edu.cn+86 150 0946 7790

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026